Sclerotherapy: Indications and safety volumes.

Tan, Matthew; Moreno, Hernan Bauza; Bechter-Hugl, Beate; Gianesini, Sergio; Connor, David; Parsi, Kurosh; Davies, Alun H

Tan, Matthew; Moreno, Hernan Bauza; Bechter-Hugl, Beate; Gianesini, Sergio; Connor, David; Parsi, Kurosh; Davies, Alun H.

Afiliación

Tan M; Department of Surgery and Cancer, Imperial College London, London, UK.
Moreno HB; Department of General Surgery, Hospital Italiano de Buenos Aires, Argentina.
Bechter-Hugl B; Department of Vascular Surgery, Centre for Lymphedema, UZ Leuven - University Hospitals Leuven, Leuven, Belgium.
Gianesini S; Department of Translational Medicine, University of Ferrara, Ferrara, Italy.
Connor D; Department of Dermatology, St Vincent's Hospital Sydney, Sydney, Australia.
Parsi K; Department of Dermatology, St Vincent's Hospital Sydney, Sydney, Australia.
Davies AH; Department of Surgery and Cancer, Imperial College London, London, UK.

Phlebology ; 39(2): 135-138, 2024 Mar.

Article en En | MEDLINE | ID: mdl-37899570

Asunto(s)

Escleroterapia; Várices; Humanos; Escleroterapia/efectos adversos; Várices/tratamiento farmacológico; Soluciones Esclerosantes/uso terapéutico; Resultado del Tratamiento

Palabras clave

chronic venous disease; foam sclerotherapy; guideline; sclerotherapy

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Várices / Escleroterapia Límite: Humans Idioma: En Revista: Phlebology Asunto de la revista: ANGIOLOGIA Año: 2024 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google